Ankylosing spondylitis microbial marker

Ankylosing spondylitis, microbiological technology, applied in the direction of microbiological determination/testing, biochemical equipment and methods, anti-inflammatory agents, etc., can solve problems such as intestinal microbial markers in patients without ankylosing spondylitis

Active Publication Date: 2017-09-29
ZHEJIANG CHINESE MEDICAL UNIVERSITY
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there are no reports of gut microbial markers in patients with ankylosing spondylitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ankylosing spondylitis microbial marker
  • Ankylosing spondylitis microbial marker
  • Ankylosing spondylitis microbial marker

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] In this example, the inventors carried out an association analysis study of the whole intestinal flora microbes from 73 ankylosing spondylitis patients and 83 healthy controls' stool samples to describe the characteristics of the fecal microbial community and functional components. In general, the inventor downloaded about 428.09Gb of high-quality sequencing data (LC healthy people) and 294Gb of high-quality sequencing data obtained from experimental sequencing to construct an ankylosing spondylitis reference gene set, and compared with the downloaded LC gene set, IGC Gene sets build a more complete gene set. Metagenome analysis showed that 17 microbial species were closely related to AS disease, 7 of which were enriched in the gut microbes of healthy people, and 10 of which were enriched in the gut microbes of AS patients.

[0074] 1. Acquisition of sequencing data

[0075] 1.1 Sample collection and DNA extraction

[0076] Patients with ankylosing spondylitis came fr...

Embodiment 2

[0103] In order to confirm that the analysis results in Example 1 can be used as an ankylosing spondylitis species marker, further compare the species abundance of 31 healthy people and 24 ankylosing spondylitis patients in the verification group, and mark the final microbial species Items are screened based on validation. The acquisition and processing of the sequencing data of the verification population is carried out with reference to Example 1.

[0104] The verification results are as follows: Among the 14 species enriched in the healthy population, 7 of them obtained high-quality verification in the verification set (p_values<0.05), and the p-value and q-value of the verification of the microbial species markers enriched in healthy people As shown in Table 2 below. The microbial species were Lachnospiraceae bacterium 6_1_63FAA, Fusobacterium mortiferum, [Bacteroides] pectinophilus, Enterobacter cloacae, Eubacterium eligens, Lachnospiraceae (Lachnospiraceae bacterium 8_...

Embodiment 3

[0115] Forty-five stool samples were used to test the individual status of the sample source.

[0116] Determine actinomycetes (Actinomyces sp.ICM47), Bifidobacterium breve (Bifidobacterium breve), Bifidobacterium (Bifidobacterium sp.12_1_47BFAA), Bifidobacterium longum (Bifidobacterium sp. longum), Collinsella aerofaciens, Bifidobacterium bifidum and Bifidobacterium pseudocatenulatum, to determine whether the abundance of these seven strains in each sample falls into the Each is in the 95% confidence interval of the abundance of the disease control group or the healthy control group, and it is determined that the abundance of these seven strains falls into the corresponding interval of the disease group, and the individual corresponding to the sample is an ankylosing spondylitis patient , it is determined that the state of the individual corresponding to the sample whose abundance of the seven strains all falls within the corresponding interval of the healthy group is a non-a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an ankylosing spondylitis microbial marker, which is formed by the following microbes: Actinomyces sp. ICM47, Bifidobacterium breve, Bifidobacterium sp.12_1_47 BFAA, Bifidobacterium longum, Collinsella aerofaciens, Bifidobacterium bifidum and Bifidobacterium pseudocatenulatum. The invention also discloses a method and a device for determining an individual condition by utilizing the ankylosing spondylitis microbial marker. Compared with a healthy group, the ankylosing spondylitis microbial marker is obviously enriched in an ankylosing spondylitis patient population, and can be used as a distinction marker of the healthy population and the ankylosing spondylitis patient population.

Description

technical field [0001] The present invention relates to the field of biomarkers, specifically, the present invention relates to microbial markers of ankylosing spondylitis, and more specifically, the present invention relates to an ankylosing spondylitis marker, an application of an ankylosing spondylitis marker, an application of Method for determining the state of an individual using ankylosing spondylitis markers, a device for determining the state of an individual using ankylosing spondylitis markers, a method for classifying a plurality of individuals using ankylosing spondylitis markers, a treatment Medicine for ankylosing spondylitis and a method for preparing medicine for treating ankylosing spondylitis. Background technique [0002] Ankylosing spondylitis (AS) is a chronic progressive inflammatory disease that mainly invades the spine and involves the sacroiliac joints and surrounding joints. The onset is mostly males aged 15 to 30. Now studies have shown that the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12Q1/06A61K45/00A61P19/08A61P29/00
CPCA61K45/00C12Q1/6883C12Q2600/136
Inventor 何志兴温成平周佳王大维邵铁娟
Owner ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap